Volume 2 - Issue 3 - May/June 2005
Insights
Commentary
09/05/2008
Emergency Stent-graft Repair for Thoracic Aortic Injury by Castelli et al. is an important paper that lends further credence to the notion that endovascular repair is rapidly becoming the new standard of care in the treatment of traumatic...
Emergency Stent-graft Repair for Thoracic Aortic Injury by Castelli et al. is an important paper that lends further credence to the notion that endovascular repair is rapidly becoming the new standard of care in the treatment of traumatic...
Emergency Stent-graft Repair for...
09/05/2008
Vascular Disease Management
Commentary
09/05/2008
Patti et al. have further added to the mounting evidence that optimal antiplatelet therapy translates to clinical benefits in PCI by reporting the results of the ARMYDA-2 trial, which was a prospective, randomized trial between a pretreatment...
Patti et al. have further added to the mounting evidence that optimal antiplatelet therapy translates to clinical benefits in PCI by reporting the results of the ARMYDA-2 trial, which was a prospective, randomized trial between a pretreatment...
Patti et al. have further added...
09/05/2008
Vascular Disease Management
Commentary
09/05/2008
Vascular injury leads to platelet activation and aggregation, and subsequent fibrin deposition and thrombosis. Antithrombin therapy alone without optimal platelet inhibition leads to an inferior outcome during percutaneous coronary...
Vascular injury leads to platelet activation and aggregation, and subsequent fibrin deposition and thrombosis. Antithrombin therapy alone without optimal platelet inhibition leads to an inferior outcome during percutaneous coronary...
Vascular injury leads to...
09/05/2008
Vascular Disease Management
Commentary
09/05/2008
CAS developments were portrayed as “The Perfect Vascular Storm” in the second issue of VDM (December 2004). These were the days before VDM had decided to adopt a new format and become a peer-review journal. In that article, I described and...
CAS developments were portrayed as “The Perfect Vascular Storm” in the second issue of VDM (December 2004). These were the days before VDM had decided to adopt a new format and become a peer-review journal. In that article, I described and...
CAS developments were portrayed...
09/05/2008
Vascular Disease Management
Feature
Original Research
09/05/2008
Blunt thoracic aortic injuries (BTAIs) due to a deceleration trauma are highly lethal and remain a therapeutic challenge. BTAIs represent only 10% of all thoracic vascular traumas and usually involve the isthmic portion of the aorta, but up...
Blunt thoracic aortic injuries (BTAIs) due to a deceleration trauma are highly lethal and remain a therapeutic challenge. BTAIs represent only 10% of all thoracic vascular traumas and usually involve the isthmic portion of the aorta, but up...
Blunt thoracic aortic injuries...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
Hemodialysis fistulas (AVFs) are an element of fundamental importance in the treatment of patients undergoing dialysis. Their correct functioning is an indispensable condition for the success of the dialysis procedure.
Hemodialysis fistulas (AVFs) are an element of fundamental importance in the treatment of patients undergoing dialysis. Their correct functioning is an indispensable condition for the success of the dialysis procedure.
Hemodialysis fistulas (AVFs) are...
09/05/2008
Vascular Disease Management
Original Contribution
09/05/2008
Percutaneous coronary intervention (PCI) with stenting has been shown to enhance platelet aggregation. Accordingly, optimization of antiplatelet therapy has a crucial role in patients undergoing percutaneous revascularization and even more...
Percutaneous coronary intervention (PCI) with stenting has been shown to enhance platelet aggregation. Accordingly, optimization of antiplatelet therapy has a crucial role in patients undergoing percutaneous revascularization and even more...
Percutaneous coronary...
09/05/2008
Vascular Disease Management
Review
09/05/2008
Recently approved by the FDA for sale in the United States, and having been employed in Europe since 1999, the Powerlink device (Endologix, Inc.) is a unibody bifurcated endograft for repair of abdominal aortic aneurysms (AAA).
Recently approved by the FDA for sale in the United States, and having been employed in Europe since 1999, the Powerlink device (Endologix, Inc.) is a unibody bifurcated endograft for repair of abdominal aortic aneurysms (AAA).
Recently approved by the FDA for...
09/05/2008
Vascular Disease Management
Case Report
09/05/2008
Management of visceral aneurysms in general, and renal artery aneurysms specifically, has traditionally involved surgical removal and revascularization. Over the last decade, options for the treatment of vascular aneurysms have come to...
Management of visceral aneurysms in general, and renal artery aneurysms specifically, has traditionally involved surgical removal and revascularization. Over the last decade, options for the treatment of vascular aneurysms have come to...
Management of visceral aneurysms...
09/05/2008
Vascular Disease Management
Case Report
09/05/2008
Hepatic artery dissection is an uncommon clinical event with few reported cases in the literature. Although rare, most reported dissections have occurred in the setting of intra-arterial hepatic artery chemotherapy or as a complication of...
Hepatic artery dissection is an uncommon clinical event with few reported cases in the literature. Although rare, most reported dissections have occurred in the setting of intra-arterial hepatic artery chemotherapy or as a complication of...
Hepatic artery dissection is an...
09/05/2008
Vascular Disease Management
